Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kite Pharma
Kite Pharma
With CAR-T marketing looming, early study highlights potential of TCR engineering
Endpoints
Fri, 08/18/17 - 12:06 pm
CAR-T
Kite Pharma
Prepping for a rapid-fire launch, Kite Pharma gets a pass from FDA on axi-cel panel review
Endpoints
Tue, 08/8/17 - 11:26 am
Kite Pharma
FDA
drug launches
axi-cel
Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race
Endpoints
Mon, 07/31/17 - 09:57 am
Kite Pharma
CAR-T
Europe
Novartis
axicabtagene ciloleucel
How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals
Investors Business Daily
Fri, 07/14/17 - 08:07 am
Novartis
CAR-T
CTL019
Kite Pharma
Bluebird Bio
Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit?
Investors Business Daily
Sun, 07/2/17 - 10:07 am
Celgene
Bluebird Bio
Kite Pharma
Juno Therapeutics
CAR-T
immuno-oncology
bb2121
3 Top-Performing Biotech Stocks This Week
Motley Fool
Fri, 06/16/17 - 09:51 am
biotech
Kite Pharma
KTE-C19
Bluebird Bio
CAR-T
Lexicon Pharmaceuticals
With Kite’s PDUFA date looming, federal court tosses Juno’s CAR-T patent challenge — for now
Endpoints
Wed, 06/14/17 - 11:43 am
Kite Pharma
PDUFA
CAR-T
patents
Juno Therapeutics
KTE-C19
Kite Pharma: How High Will It Fly?
Seeking Alpha
Tue, 06/13/17 - 10:33 am
Kite Pharma
CAR-T
Novartis' CAR-T stacks up to Kite in lymphoma
BioPharma Dive
Wed, 06/7/17 - 07:04 pm
Novartis
CAR-T
Kite Pharma
CTL019
axi-cel
lymphoma
Kite Pharma's ASCO ads aim to prep docs on CAR-T ahead of FDA approval
Fierce Pharma
Mon, 06/5/17 - 12:06 pm
Kite Pharma
CAR-T
FDA
ASCO 2017
7 Areas to watch from the ASCO abstracts
BioPharma Dive
Fri, 05/19/17 - 11:35 am
ASCO 2017
oncology
Incyte
Merck
Eli Lilly
CAR-T
NewLink Genetics
Amgen
Roche
Kite Pharma
Juno Therapeutics
After Kite Pharma stuns analysts with news of a death in lead CAR-T study, safety questions sour launch forecast
Endpoints
Tue, 05/9/17 - 10:23 am
Kite Pharma
CAR-T
One of Kite Pharma’s CAR-T patients died from cerebral edema, triggering a safety alarm
Endpoints
Mon, 05/8/17 - 11:33 am
Kite Pharma
CAR-T
cerebral edema
KTE-C19
Juno Therapeutics
Novartis Snags Coveted FDA 'Breakthrough' Label for CAR-T, Trial Results Still Under Wraps
TheStreet.com
Tue, 04/18/17 - 09:49 am
Novartis
Kite Pharma
FDA
CAR-T
breakthrough status
CTL019
Novartis Keeps 'JULIET' Study Results Close as Investors and Rival Kite Pharma Wait
TheStreet.com
Fri, 04/7/17 - 09:45 am
Novartis
Kite Pharma
CTL019
diffuse large B-cell lymphoma
Kite Pharma hits its Q1 deadline on filing a BLA for its pioneering CAR-T, posts improved data
Endpoints
Fri, 03/31/17 - 10:06 pm
Kite Pharma
CAR-T
KTE-C19
non-Hodgkin's lymphoma
Novartis Makes Plans For Its Cancer-Killing T Cells
Forbes
Wed, 03/29/17 - 10:35 pm
Novartis
CAR-T
Kite Pharma
Biotechs Breaking Out On Drug Development News
Forbes
Fri, 03/3/17 - 09:21 am
Bluebird Bio
Esperion Therapeutics
Amicus Therapeutics
Kite Pharma
Four biotech stocks surging on optimism about drug trials, product launches
Marketwatch
Thu, 03/2/17 - 03:43 pm
clinical trials
Bluebird Bio
Amicus Therapeutics
Kite Pharma
NeuroDerm
Kite Pharma launches public stock sale following recent price surge
Marketwatch
Thu, 03/2/17 - 10:43 am
Kite Pharma
stock offering
non-Hodgkins lymphoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »